Ontology highlight
ABSTRACT: Background
Cardiac reverse remodeling occurs in a small subset of patients with heart failure treated with guideline-directed therapies. This phenomenon, which is defined by reduced ventricular dilatation and improved systolic function, is most common in patients receiving left ventricular assist device (LVAD) therapy. Identifying therapeutic targets for initiating reverse remodeling is an area of great clinical interest, because these patients experience improved outcomes and quality of life. Targets may be discovered among the unique molecular changes associated with LVAD-induced partial myocardial functional recovery; however, the mechanisms underlying this favorable response are incompletely understood.Methods
To identify molecular signatures of recovery, we studied pai
SUBMITTER: Martin TG
PROVIDER: S-EPMC12778997 | biostudies-literature | 2026 Jan
REPOSITORIES: biostudies-literature